Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.550
-0.140 (-2.99%)
At close: Jul 20, 2026, 4:00 PM EDT
4.550
0.00 (0.00%)
Pre-market: Jul 21, 2026, 4:16 AM EDT
Lexeo Therapeutics Employees
Lexeo Therapeutics had 59 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
59
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,483,068
Market Cap
357.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 59 | 0 | - |
| Dec 31, 2025 | 59 | -13 | -18.06% |
| Dec 31, 2024 | 72 | 14 | 24.14% |
| Dec 31, 2023 | 58 | 34 | 141.67% |
| Dec 31, 2021 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Rocket Pharmaceuticals | 202 |
| Sutro Biopharma | 133 |
| Zentalis Pharmaceuticals | 106 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| Atea Pharmaceuticals | 55 |
| X4 Pharmaceuticals | 45 |
LXEO News
- 21 days ago - Lexeo Therapeutics Transcript: Fireside chat - Transcripts
- 25 days ago - Lexeo Therapeutics Transcript: AGM 2026 - Transcripts
- 25 days ago - Lexeo Therapeutics price target lowered to $9 from $12 at JPMorgan - TheFly
- 4 weeks ago - Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia - GlobeNewsWire
- 5 weeks ago - Lexeo Therapeutics Transcript: Investor update - Transcripts
- 5 weeks ago - Lexeo Therapeutics Slides: Investor update - Filings
- 5 weeks ago - Lexeo Therapeutics Press release: Investor update - Filings
- 5 weeks ago - Lexeo finalizes SUNRISE-FA 2 pivotal trial protocol, statistical analysis plan - TheFly